Literature DB >> 21898380

Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors.

Jehad Charo1, Cynthia Perez, Christian Buschow, Ana Jukica, Melinda Czeh, Thomas Blankenstein.   

Abstract

Adoptive T-cell therapy (ATCT) can result in tumor rejection, yet the behavior and fate of the introduced T cells remain unclear. We developed a novel bioluminescence mouse model, which enabled highly sensitive detection of T-cell signals at the single-cell level. Transferred T cells preferentially accumulated within antigen-positive tumors, relative to the unaffected areas in each mouse, and remarkably, expanded within both lymphopenic and P14 mice. This expansion was controlled and efficient, as evaluated by bioluminescence imaging (BLI) of the T-cell signals and by tumor rejection respectively. Analysis of the population dynamics of transferred T cells in ATCT of large tumors revealed that proliferation did not always follow a simple linear pattern of expansion, but showed an oscillating pattern of expansion and contraction that was often followed by a rebound, until full tumor rejection was achieved. Furthermore, visualizing the recall response showed that the transferred T cells responded expeditiously, indicating the ability of these cells to survive, establish memory and compete with endogenous T cells for as long as 1 year after rejecting the tumor.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21898380     DOI: 10.1002/eji.201141452

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.

Authors:  Anning Li; Yue Wu; Jenny Linnoila; Benjamin Pulli; Cuihua Wang; Matthias Zeller; Muhammad Ali; Grant K Lewandrowski; Jinghui Li; Benoit Tricot; Edmund Keliher; Gregory R Wojtkiewicz; Giulia Fulci; Xiaoyuan Feng; Bakhos A Tannous; Zhenwei Yao; John W Chen
Journal:  Cancer Immunol Immunother       Date:  2016-10-08       Impact factor: 6.968

2.  NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.

Authors:  Robin Parihar; Charlotte Rivas; Mai Huynh; Bilal Omer; Natalia Lapteva; Leonid S Metelitsa; Stephen M Gottschalk; Cliona M Rooney
Journal:  Cancer Immunol Res       Date:  2019-01-16       Impact factor: 11.151

3.  Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001.

Authors:  Else-Marit Inderberg-Suso; Sissel Trachsel; Kari Lislerud; Anne-Marie Rasmussen; Gustav Gaudernack
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

Review 4.  Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.

Authors:  Mikhail O Durymanov; Andrey A Rosenkranz; Alexander S Sobolev
Journal:  Theranostics       Date:  2015-06-08       Impact factor: 11.556

Review 5.  Molecular imaging in tracking tumor-specific cytotoxic T lymphocytes (CTLs).

Authors:  Zhiyi Liu; Zheng Li
Journal:  Theranostics       Date:  2014-07-28       Impact factor: 11.556

Review 6.  Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".

Authors:  Michael Karl Melzer; Arturo Lopez-Martinez; Jennifer Altomonte
Journal:  Biomedicines       Date:  2017-02-10

7.  T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.

Authors:  Nathalie E Blachère; Dana E Orange; Bianca D Santomasso; Jessica Doerner; Patricia K Foo; Margaret Herre; John Fak; Sébastien Monette; Emily C Gantman; Mayu O Frank; Robert B Darnell
Journal:  Eur J Immunol       Date:  2014-11       Impact factor: 5.532

8.  Preventing tumor escape by targeting a post-proteasomal trimming independent epitope.

Authors:  Ana Textor; Karin Schmidt; Peter-M Kloetzel; Bianca Weißbrich; Cynthia Perez; Jehad Charo; Kathleen Anders; John Sidney; Alessandro Sette; Ton N M Schumacher; Christin Keller; Dirk H Busch; Ulrike Seifert; Thomas Blankenstein
Journal:  J Exp Med       Date:  2016-10-03       Impact factor: 14.307

9.  Interleukin-7 Modulates Anti-Tumor CD8+ T Cell Responses via Its Action on Host Cells.

Authors:  Katrin Deiser; Diana Stoycheva; Ute Bank; Thomas Blankenstein; Thomas Schüler
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240

10.  Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence.

Authors:  Rajiv Ramasawmy; S Peter Johnson; Thomas A Roberts; Daniel J Stuckey; Anna L David; R Barbara Pedley; Mark F Lythgoe; Bernard Siow; Simon Walker-Samuel
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.